Table 12 Summary statistics for surgery for patients with no response to systemic therapy
From: The cost of unresectable stage III or stage IV melanoma in Italy
Overall | First-line therapy | Second-line therapy | Third-line therapy | ||
|---|---|---|---|---|---|
N | 119 | 94 | 78 | 27 | |
Patients with any surgery | N | 23 | 23 | 10 | 3 |
% | 19,3% | 24,5% | 12,8% | 11,1% | |
Type of surgery | |||||
Resection of primary tumor | % | 3% | 3% | 0% | 0% |
Lymph node resection | % | 10% | 9% | 2% | 1% |
All other visceral | % | 10% | 7% | 3% | 3% |
Brain metastases | % | 4% | 2% | 2% | 0% |
Isolated limb perfusion | % | 0% | 0% | 0% | 0% |
Biopsy | % | 6% | 6% | 1% | 1% |
Distant skin, subcutaneous or node | % | 7% | 6% | 2% | 0% |
Lung | % | 0% | 0% | 0% | 0% |
Total surgery cost per patient with any surgery (€ 2009) | Mean | 7.119 | 4.841 | 5.583 | 7.780 |
Total surgery cost per patient (€ 2009) | Mean | 1.376 | 1.185 | 716 | 864 |